Originalarbeiten

Schnellbächer GJ, Rajkumar R, Veselinović T, Ramkiran S, Hagen J, Shah NJ, Neuner I. Structural alterations of the insula in depression patients – A 7-Tesla-MRI study. NeuroImage: Clinical. 2022;36:103249. doi: 10.1016/j.nicl.2022.103249

Paschou P, Jin Y, Müller-Vahl K, Veselinović T,Black KJ. Enhancing neuroimaging genetics through meta-analysis for Tourette syndrome (ENIGMA-TS): A worldwide platform for collaboration. Front Psychiatry. 2022 Aug 18;13:958688.

Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde P-E, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Rottmann A. Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. The Lancet Psychiatry 2022, 9(4), 291–306. doi: 10.1016/S2215-0366(22)00032-3; *Veselinović T member of the COMBINE Study Group

Veselinović T, Rajkumar R, Amort L, Junger J, Shah NJ, Fimm B, Neuner I. Connectivity Patterns in the Core Resting-State Networks and Their Influence on Cognition. Brain Connect. 2022 May;12(4):334-347. doi: 10.1089/brain.2020.0943.

Neuner I, Veselinović T*, Ramkiran S, Rajkumar R, Schnellbaecher GJ, Shah NJ. 7T ultra-high-field neuroimaging for mental health: an emerging tool for precision psychiatry? Transl Psychiatry. 2022 Jan 26;12(1):36. doi: 10.1038/s41398-022-01787-3. PMID: 35082273;* equal contribution

Kaulen N, Rajkumar R, Régio Brambilla C, Mauler J, Ramkiran S, Orth L, Sbaihat H1, Lang M, Wyss C, Rota Kops E, Scheins J, Neumaier B, Ermert J, Herzog H, Langen KJ, Lerche C, Shah NJ, Veselinović T, Neuner I. GABAA and mGluR5 receptor specific parametric PET atlas construction - PET/MR data processing pipeline, validation and application. Hum Brain Mapp. 2022 Jan 25. doi: 10.1002/hbm.25778. Epub ahead of print. PMID: 35076125.

Sbaihat H, Rajkumar R, Ramkiran S, Assi A, Shah NJ, Veselinović T*, Neuner I*. Test-retest stability of the spontaneous brain activity and the functional connectivity in the core resting state networks assessed with ultra-field 7-Tesla resting-state fMRI. Human Brain Mapping. 2022;43(6):2026-2040. doi: 10.1002/hbm.25771;* equal contribution

Régio Brambilla C, Veselinović T, Matusch A, Mauler J, Rajkumar R, Ruch A, Orth L, Ramkiran S, Sbaihat H, Kaulen N, Khudeish NY, Wyss W, Heekeren C, Kawohl W, Kops E, Tellmann L, Scheins J, Boers F, Neumaier N, Ermert E, Lang M, Stüsgen S, Herzog H, Langen KJ, Shah NJ, Lerche CW*, Neuner N*. mGluR5 Binding During a Mismatch Negativity Task in a Multimodal Protocol with [11C]ABP688 PET/MR-EEG. Transl Psychiatry. 2022;12(1):6. doi.org/10.1038/s41398-021-01763-3

Sbaihat H, Rajkumar R, Ramkiran S, Assi A, Shah NJ, Veselinović T*, Neuner I*. Dynamics of task-induced modulation of spontaneous brain activity and functional connectivity in the triple resting-state networks assessed using the visual oddball paradigm. PLoS One. 2021 Nov 4;16(11):e0246709. doi: 10.1371/journal.pone.0246709. ECollection 2021; * equal contribution

Boccadoro S, Wagels L, Puiu A, Votinov M, Weidler C, Veselinović T, Demko Z, Raine A, Neuner I. A meta-analysis on shared and distinct neural correlates of the decision-making underlying altruistic and retaliatory punishment. Hum Brain Mapp. 2021 Dec 1;42(17):5547-5562. doi: 10.1002/hbm.25635. Epub 2021 Aug 20

Akkoc Altinok DC, Rajkumar R, Nießen D, Sbaihat H, Kersey M, Shah NJ, Veselinović T*, Neuner I* Common neurobiological correlates of resilience and personality traits within the triple resting-state brain networks assessed by 7-Tesla ultra-high field MRI. Scientific reports. 2021 Jun 2;11(1):11564. doi: 10.1038/s41598-021-91056-y.; * equal contribution

Rajkumar R, Régio Brambilla C*, Veselinović T*, Bierbrier J, Wyss C, Ramkiran S, Orth L, Lang M, Rota Kops E, Mauler J, Scheins J, Neumaier B, Ermert J, Herzog H, Langen KJ, Binkofski FC, Lerche C, Shah NJ, Neuner I. Excitatory-inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET-MR-EEG imaging. Transl Psychiatry. 2021 Jan 18;11(1):60. doi: 10.1038/s41398-020-01160-2; * equal contribution

Régio Brambilla C*, Veselinović T*, Rajkumar R, Mauler J, Orth L, Ruch A, Ramkiran S, Heekeren K, Kawohl W, Wyss C, Kops ER, Scheins J, Tellmann L, Boers F, Neumaier B, Ermert J, Herzog H, Langen KJ, Jon Shah N, Lerche C, Neuner I. mGluR5 receptor availability is associated with lower levels of negative symptomsand better cognition in male patients with chronic schizophrenia. Hum Brain Mapp. 2020 Jul;41(10):2762-2781. doi: 10.1002/hbm.24976; * equal contribution

Veselinović T, Scharpenberg M, Heinze M, Cordes J, Mühlbauer J, Juckel G, Rüther E, Timm J, Gründer G. on behalf of the NeSSy Study Group. Estimated Dopamine D2 Receptor occupancy from plasma concentrations of four different antipsychotics and the subjective experience of physical and mental well-being in schizophrenia: Results from the randomized NeSSy trial. J Clin Psychopharmacol. 2019 Nov/Dec;39(6):550-560. doi: 10.1097/JCP.0000000000001131

Schoretsanitis G, Haen E, Hiemke C, Endres K, Ridders F, Veselinovic T, Gründer G, Paulzen M. Pharmacokinetic correlates of venlafaxine: associated adverse reactions. Eur Arch Psychiatry Clin Neurosci. 2019 Oct;269(7):851-857. doi: 10.1007/s00406-019-01005-0.

Veselinović T, Scharpenberg M, Heinze M, Cordes J, Mühlbauer J, Juckel G, Habel U., Rüther E, Timm J, Gründer G. on behalf of the NeSSy Study Group. Disparate Effects of First and Second Generation Antipsychotics on Cognition in Schizophrenia - Findings from the randomized NeSSy Trial. European Neuropsychopharmacology, Eur Neuropsychopharmacol. 2019 Jun;29(6):720-739.

Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G. The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia. Psychopharmacology (Berl) 2018; 235(8): 2221-2232.

Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G. Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion. Neuropsychiatr Dis Treat. 2018; 14: 1125-1138.

Paulzen M, Lammertz SE, Gründer G, Veselinovic T, Hiemke C, Tauber SC. Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants: Erratum. Int Clin Psychopharmacol 2016; 31(5): 300.

Schoretsanitis G, Haen E, Hiemke C, Gründer G, Stegmann B, Schruers KR, Veselinovic T, Lammertz SE, Paulzen M. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations? Int Clin Psychopharmacol 2016; 31(5):259-64.

Paulzen M, Gründer G, Veselinovic T, Wolf B, Hiemke C, Lammertz SE. Duloxetine enters the brain - But why is it not found in the cerebrospinal fluid. J Affect Disord 2016; 189: 159-63.

Paulzen M, Lammertz SE, Gründer G, Veselinovic T, Hiemke C, Tauber SC. Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants. Int Clin Psychopharmacol 2016; 31(3): 119-26.

Veselinovic T, Vernaleken I, Janouschek H, Kellermann T, Paulzen M, Cumming P, Gründer G. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers. Psychopharmacology (Berl) 2015 ; 232(9): 1607-17.

Paulzen M, Groppe S, Tauber SC, Veselinovic T, Hiemke C, Gründer G. Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid. J Clin Psychiatry 2015; 76(1): 25-31.

Paulzen M, Gründer G, Tauber SC, Veselinovic T, Hiemke C, Groppe SE. Distribution pattern of mirtazapine and normirtazapine in blood and CSF. Psychopharmacology (Berl) 2015; 232(4): 807-13.

Paulzen M, Gründer G, Orlikowsky T, Gräf CM, Hoeltzenbein M, Veselinovic T. Suicide Attempt During Late Pregnancy With Quetiapine: Nonfatal Outcome Despite Severe Intoxication. J Clin Psychopharmacol 2015; 35(3): 343-4.

Paulzen M, Lammertz SE, Veselinovic T, Goecke TW, Hiemke C, Gründer G. Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood. Int Clin Psychopharmacol 2015; 30(5): 249-54.

Gründer G, Veselinovic T, Paulzen M. [Antidepressive agents and suicidal tendencies.] Nervenarzt 2014; 85(9): 1108-16.

Paulzen M, Veselinovic T, Gründer G. Effects of psychotropic drugs on brain plasticity in humans. Restor Neurol Neurosci 2014; 32(1): 163-81.

Veselinovic T, Paulzen M, Gründer G. Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression. Expert Rev Neurother 2013; 13(11): 1141-59.

Veselinovic T, Schorn H, Vernaleken IB, Hiemke C, Zernig G, Gur R, Gründer G. Effects of antipsychotic treatment on cognition in healthy subjects. J Psychopharmacol 2013; 27(4): 374-385.

Gründer G, Veselinovic T, Paulzen M. [Basic principles of therapy with neuropsychotropic drugs]. Nervenarzt 2012; 83(9): 1193-208.

Veselinovic T, Schorn H, Vernaleken IB, Schiffl K, Klomp M, Gründer G. Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. J Clin Psychopharmacol 2011; 31: 214-20.

Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I. Therapeutic Plasma Concentrations of Antidepressants and Antipsychotics: Lessons from PET Imaging. Pharmacopsychiatry 2011; 44: 236-48.

Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol 2010; 13(7): 951-60.

Veselinovic T, Himmerich H. Antihistaminerge Antipsychotika verursachen Gewichtszunahme. [Antihistaminergic antipsychotics cause weight gain.] Nervenarzt 2010; 81(3): 329-34.

Veselinovic T, Louis F, Himmerich H. Dialektisch-Behaviorale Therapie bei Borderline-Persönlichkeitsstörung Anwendung und Evaluation. psychoneuro 2008; 34 (10): 467-470.

Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol 2008; 28(6): 608-617.

Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I. Brain and plasma pharmacokinetics of Aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.Am J Psychiatry 2008; 988-995.

Veselinovic T, Bauer J. The importance of out-patient departments for patients with epilepsy?An evaluation in 503 patients. Z Epileptol 2006; 19: 21-23.

Weitere Informationen zu den wissenschaftlichen Veröffentlichungen entnehmen Sie bitte der Literatur-Datenbank PubMed

Buchbeiträge